Stay updated on LOU064 Safety & Tolerability Clinical Trial

Sign up to get notified when there's something new on the LOU064 Safety & Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LOU064 Safety & Tolerability Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page content appears unchanged in substance; only minor formatting differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T21:13:02.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0 release tag. The page now informs users about potential delays due to funding lapses and provides links to official status sources.
    Difference
    2%
    Check dated 2025-10-06T08:58:35.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Added Revision: v3.1.0 - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2
    Difference
    0.3%
    Check dated 2025-09-29T07:33:05.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-14T23:20:10.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T19:54:48.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and specific diseases. Notably, the drug remibrutinib has been introduced, indicating a focus on pharmaceutical preparations.
    Difference
    2%
    Check dated 2025-08-31T12:33:35.000Z thumbnail image

Stay in the know with updates to LOU064 Safety & Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LOU064 Safety & Tolerability Clinical Trial page.